BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33396615)

  • 1. The Role of Haptoglobin Polymorphism in Cardiovascular Disease in the Setting of Diabetes.
    Somer S; Levy AP
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype.
    Blum S; Vardi M; Brown JB; Russell A; Milman U; Shapira C; Levy NS; Miller-Lotan R; Asleh R; Levy AP
    Pharmacogenomics; 2010 May; 11(5):675-84. PubMed ID: 20415560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?
    Vardi M; Levy AP
    Curr Diab Rep; 2012 Jun; 12(3):274-9. PubMed ID: 22427005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
    Dalan R; Liuh Ling G
    Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
    Hochberg I; Berinstein EM; Milman U; Shapira C; Levy AP
    Curr Diab Rep; 2017 Jun; 17(6):42. PubMed ID: 28451949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haptoglobin 2-2 genotype is not associated with cardiovascular risk in subjects with elevated glycohemoglobin-results from the Bruneck Study.
    Pechlaner R; Kiechl S; Willeit P; Demetz E; Haun M; Weger S; Oberhollenzer F; Kronenberg F; Bonora E; Weiss G; Willeit J
    J Am Heart Assoc; 2014 May; 3(3):e000732. PubMed ID: 24837587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient selection and vitamin E treatment in diabetes mellitus.
    Goldenstein H; Levy NS; Lipener YT; Levy AP
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):319-26. PubMed ID: 23469912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.
    Vardi M; Blum S; Levy AP
    Eur J Intern Med; 2012 Oct; 23(7):628-32. PubMed ID: 22939808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.
    Levy Y; Blum S; Levy AP
    Clin Nutr; 2009 Oct; 28(5):581-2. PubMed ID: 19464773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and Haptoglobin 2-2 genotype: A double-blinded cross-over study.
    Alshiek JA; Dayan L; Asleh R; Blum S; Levy AP; Jacob G
    Diabetes Res Clin Pract; 2017 Sep; 131():200-207. PubMed ID: 28759833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL.
    Goldenstein H; Levy NS; Ward J; Costacou T; Levy AP
    J Diabetes Res; 2018; 2018():6125420. PubMed ID: 29888289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
    Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
    Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
    Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.
    Levy AP; Hochberg I; Jablonski K; Resnick HE; Lee ET; Best L; Howard BV;
    J Am Coll Cardiol; 2002 Dec; 40(11):1984-90. PubMed ID: 12475459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haptoglobin genotype and its role in diabetic cardiovascular disease.
    Costacou T; Levy AP
    J Cardiovasc Transl Res; 2012 Aug; 5(4):423-35. PubMed ID: 22447230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.
    Levy AP
    Isr Med Assoc J; 2004 May; 6(5):308-10. PubMed ID: 15151377
    [No Abstract]   [Full Text] [Related]  

  • 17. Haptoglobin: basic and clinical aspects.
    Levy AP; Asleh R; Blum S; Levy NS; Miller-Lotan R; Kalet-Litman S; Anbinder Y; Lache O; Nakhoul FM; Asaf R; Farbstein D; Pollak M; Soloveichik YZ; Strauss M; Alshiek J; Livshits A; Schwartz A; Awad H; Jad K; Goldenstein H
    Antioxid Redox Signal; 2010 Feb; 12(2):293-304. PubMed ID: 19659435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.
    Farbstein D; Blum S; Pollak M; Asaf R; Viener HL; Lache O; Asleh R; Miller-Lotan R; Barkay I; Star M; Schwartz A; Kalet-Littman S; Ozeri D; Vaya J; Tavori H; Vardi M; Laor A; Bucher SE; Anbinder Y; Moskovich D; Abbas N; Perry N; Levy Y; Levy AP
    Atherosclerosis; 2011 Nov; 219(1):240-4. PubMed ID: 21722898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study.
    Adams JN; Cox AJ; Freedman BI; Langefeld CD; Carr JJ; Bowden DW
    Cardiovasc Diabetol; 2013 Feb; 12():31. PubMed ID: 23399657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.